7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Company News for June 16, 2011

by Zacks Equity Research

June 16, 2011 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.


• Share prices of Scotts Miracle-Gro Company (NYSE:SMG) dipped 6.02% after the company reduced its earnings estimate for the fiscal year 2011

• Shares of Owens-Illinois (NYSE:OI) dropped 13.54% to close at $25.54 after the company said its second quarter earnings figures could fall due to a jump in manufacturing and delivery expenses

• Johnson & Johnson (NYSE:JNJ) is reportedly pulling out of the drug-coated heart stent market because of continually declining sales. The global market for this segment is valued at $4 billion

• Analysts at Jefferies & Co. initiated coverage on shares of General Mills, Inc. (NYSE:GIS) with "Hold" rating and a target price of $40

• Analysts at Jefferies & Co. initiated coverage on Shares of Kellogg (NYSE:K) with "Underperform" rating and also lowered the target price of the stock to $47

• Analysts at Auriga downgraded Myriad Genetics (NASDAQ:MYGN) to "Hold" rating from "Buy" rating, cutting the target price to $25 from $27

• Analysts at Wedbush downgraded shares of Ceradyne (NASDAQ:CRDN) to "Neutral" rating from "Outperform" rating

• Analysts at Wedbush downgraded shares of AngioDynamics (NASDAQ:ANGO) to an "Underperform" rating

• Wells Fargo upgraded Hospitality Properties Trust (NYSE:HPT) to "Outperform" rating from "Market Perform" rating

• Pharma company AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has priced its public offering of 5.75 million shares at $17.50 per share. This offering is expected to bring in $100.6 million before expenses, which will be used for general corporate needs

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.